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For a number of years it has been clear that nicotinic acid is synthesized
by at least some mamnials. The amount of this.vitamin retained in the
body of a rat plus that excreted may far exceed the dietary intake.'-' On a
diet containing adequate protein the dog appears not to need exogenous
nicotinic acid.4 Recently it has been show-n that nicotinic acid synthesis in
the rat,3' 5- man,8 I the horse10 and the cotton rat'0 is increased when the
diet is high in tryptophane.
It has likewise been shown by Woolley" and by Kodicek, Carpenter and
Harris"2 that nicotinic acid and tryptophane are interchangeable in coun-
teracting the pellagragenic effects of 3-acetyl pyridine, indQle-3-acetic acid,
and a factor present in corn that may be related to one of these.
As pointed out by Rosen, Huff and Perlzweig5 these facts suggest that
tryptophane may serve as natural precursor of nicotinic acid. Other inter-
pretations are possible, however."
Evidence in support of the hypothesis that tryptophane is a precursor of
nicotinic acid and that kynurenine is an intermediate in the conversion
comes from a study of a mutant strain of Neurospoia crassa. This mutant
strain, designated 65001, descended fromn a conidium irradiated with 9400
ergs of ultraviolet per square millimeter. The manner of treatment and of
isolating and detecting mutant stains has been described elsewhere.'4
Mutant strains of Neurospora requiring exogenous tryptophane for
growth are known.'5 Other strains have been studied that will not grow
unless nicotinic acid or a related compound is supplied in the medium.'6
In certain of these strains the requirements are specific. Tryptophaneless
strain 10575 will not respond to nicotinic acid, and nicotinic acid-requiring
strains 3416 and 4540 will not grow on tryptophane. Strain 65001, on the
other hand, grows if supplied with either tryptophane or nicot.nic acid.
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In outcrosses to wild-type strains, mutant 65001 behaves as though it dif-
fered from normal by a single gene. Asci from the cross carry four asco-
spores that give rise to cultures that grow in the absence of both trypto-
phane and nicotinic acid and four spores that give cultures which, like the
mutant parent, require either but not both of these growth factors. The
gene in which 65001 and wild type differ is not sex linked. Its genetic rela-
tion to genes carried in mutant form by previously reported tryptophane-
less and nicotinicless strains has not yet been completely established.
The behavior of strain 65001 suggested to us that it, like the rat, might be
able to make nicotinic acid from tryptophane. Kynurenine, known as a
product of tryptophane metabolism in mammals,'7 l1 insects"' 20 and bac-
teria,20 suggested itself as a possible intermediate in this process. Tests of
1-kynurenine, isolated from the urine of rabbits and kindly made available
to us by Professor S. Lepkovsky of the University of California, showed it to
be active in promoting growth of mutant 65001. As determined by three-
day growth in 125-ml. flask cultures,'16 approximately 1.6 micromoles of 1-
kynurenine gives half-maximum growth. The corresponding values for
nicotinamide and l-tryptophane are 1.4 and 9.S micromoles, respectively.
Following the method of Butenandt, et al.' " dlkynurenine was synthe-
sized. It proved to have half the activity of the natural material showing
that the d-isomer is not utilized as a growth factor by 65001.
Like the mammal, strain 65001 produces an excess of nicotinic acid (or
amide) when grown in the presence of an excess of tryptophane but not
when grown on an amount just sufficient for growth. Thus four 500-ml.
flask cultures of 65001, made up with 100 ml. of culture medium each, two
containing 2 mg. dl-tryptophane per 100 ml. medium and two containing
four times as much, were grown for seven days and the culture medium
tested for nicotinic acid. The lesser amount of tryptophane was adequate
for growth of strain 65001. Following replenishment of sugar and biotin,
the culture media were tested for ability to support growth of mutant 3416,
a strain which appears to be specific for nicotinic acid or nicotinamide.'6
The media initially high in tryptophane gave good growth while those ini-
tially low in tryptophane gave very little. While it is conceivable that the
compound accumulated is not nicbtinic acid or nicotinamide but a com-
pound of unknown nature with similar biological activity, this seems un-
likely.
An experiment made in a similar manner shows that when 65001 is sup-
plied dl-kynurenine in an amount just sufficient for maximum growth (500
micrograms per 20-ml. medium),, no nicotinic acid is given off in the culture
medium in 12 days. But when the kynurenine is increased fourfold, nico-
tinic acid accumulates in the culture medium in an amount sufficient for
maximum growth of strain 3416-at least 0.5 microgram per milliliter of
culture medium.
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These experiments lend stroiig support to the view that Neurospora con-
verts tryptophane to nicotinic acid by way of kynurenine.
Since kynurenine is active as a growth factor for strain 39401 which was
used as an assay strain by Bonner and Beadle'16 in the isolation of two nico-
tinic acid precursors accumulated by strain 4540, the question arises as to
the relation of kynurenine to these precursors. Elementary analyses of the
strain 4540 precursors reported by Bonner and Beadle show that they can-
not be ky,nurenine, a conclusion consistent with independent evidence indi-
cating that they both contain a pyridine ring."6 A reexamination of the
properties of mutant 39401 shows that it, like mutant 65001, grows when
supplied tryptophane. These two strains may be alike genetically; at-
tempts to cross them have so far been unsuccessful.
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FIGURE 1
Proposed scheme of synthesis of tryptophane and nicotinic acid in Neurospora.
On the basis of the evidence so far available, we suggest that the synthe-
sis of tryptophane and nicotinic acid in Neurospora takes place according to
the scheme shown in figure 1. It is clear that this scheme is incomplete.
The part played in it by the gene in which strain 65001 differs from wild
type is not yet entirely clear but we suspect that it is concerned with one of
the steps between anthranilic acid and indole. In addition the evidence
strongly suggests that one of the functions of nicotinic acid is to act cata-
lytically in the synthesis of tryptophane.
Summary.-On the basis of the growth responses of Neurospora mutant
strains to tryptophane, nicotinic acid and kynurenine, it is postulated that
nicotinic acid is normally formed from tryptophane with kynurenine as an
intermediate. If this conclusioni is correct, kynurenine has a biological sig-
nificance not heretofore suspected. Whether kynurenine serves as an in-
157
BOTANY: T. H. GOODSPEED
termediate between tryptophane and nicotinic acid in the mammal remains
to be determined.
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ON THE EVOLUTION OF THE GENUS NICOTIANA*
By T. H. GOODSPEED
DEPARTMENT OF BOTANY, UNIVERSITY OF CALIFORNIA
Communicated May 7, 1947
Taxonomic Status.-The relatively advanced family Solanaceae is allied
to such families as the Labiatae, Hydrophyllaceae, Boraginaceae and Pole-
moniaceae but most closely related to the Nolanaceae and Scrophulariaceae.
The approximately seventy-five genera have been organized in five to nine
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